Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Johnson & Johnson's Official Statement in Response to Today's Verdict in St. Louis Trial

Johnson & Johnson
Posted on: 13 Jul 18
Johnson & Johnson's Official Statement in Response to Today's Verdict in St. Louis Trial

PR Newswire

NEW BRUNSWICK, N.J., July 12, 2018

NEW BRUNSWICK, N.J. , July 12, 2018/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) issued the following statement regarding today's verdict in the St. Louis court.

"Johnson & Johnson is deeply disappointed in the verdict, which was the product of a fundamentally unfair process that allowed plaintiffs to present a group of 22 women, most of whom had no connection to Missouri, in a single case all alleging that they developed ovarian cancer. The result of the verdict, which awarded the exact same amounts to all plaintiffs irrespective of their individual facts, and differences in applicable law, reflects that the evidence in the case was simply overwhelmed by the prejudice of this type of proceeding.  Johnson & Johnson remains confident that its products do not contain asbestos and do not cause ovarian cancer and intends to pursue all available appellate remedies.  Every verdict against Johnson & Johnson in this court that has gone through the appeals process has been reversed and the multiple errors present in this trial were worse than those in the prior trials which have been reversed."

 

 

View original content with multimedia:http://www.prnewswire.com/news-releases/johnson--johnsons-official-statement-in-response-to-todays-verdict-in-st-louis-trial-300680519.html

SOURCE Johnson & Johnson

PR Newswire
www.prnewswire.com

Last updated on: 13/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.